11/19/2014 - 3:33 PM EST - Annidis Corporation : announced that Retinal Consultants of Arizona (RCA) has added Annidis RHA instrument into its patient-based offering across the state of Arizona. RCA is one of America's leading Retinal and Vitreous clinical research and patient treatment facilities. Annidis Corporation
shares V.RHA are trading unchanged at $0.25.
